Organon Earnings
NYSE: OGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.81+0.06 (+0.44%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Organon earnings summary
In its most recent report on Jul 31, 2026 (Q2 2026), OGN posted EPS of $0.40. Revenue for the quarter was $1.56 billion. Quarterly EPS is down 28.6% from the same quarter a year earlier.
Across the last 16 reports, OGN shares moved an average of 5.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
OGN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 31, 2026 | — | $0.40 | — | +0.4% |
| May 4, 2026 | — | $0.55 | — | +0.4% |
| Feb 24, 2026 | — | $-0.78 | — | -10.0% |
| Nov 10, 2025 | — | $0.61 | — | -4.4% |
| Aug 6, 2025 | — | $0.56 | — | +2.4% |
| May 2, 2025 | — | $0.33 | — | -9.2% |
| Feb 28, 2025 | — | $0.42 | — | +3.6% |
| Nov 1, 2024 | — | $1.38 | — | -11.2% |
| Aug 7, 2024 | — | $0.75 | — | +1.0% |
| May 3, 2024 | — | $0.78 | — | +4.1% |
| Feb 26, 2024 | — | $2.12 | — | +5.1% |
| Nov 3, 2023 | — | $0.23 | — | -16.4% |
| Aug 9, 2023 | — | $0.95 | — | -2.9% |
| May 5, 2023 | — | $0.69 | — | -7.3% |
| Feb 27, 2023 | — | $0.42 | — | -7.7% |
| Nov 4, 2022 | — | $0.89 | — | +3.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.